Seoul, South Korea

Min Seok Choi

USPTO Granted Patents = 17 

Average Co-Inventor Count = 1.5

ph-index = 4

Forward Citations = 42(Granted Patents)


Location History:

  • Pusan, KR (2012)
  • Ichon, KR (2013)
  • Ichon-shi, KR (2012 - 2014)
  • Seoul, KR (2012 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
17 patents (USPTO):Explore Patents

Title: Min Seok Choi: Innovator in Fibrosis Treatment

Introduction

Min Seok Choi is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical research, particularly in the treatment of fibrosis. With a total of 17 patents to his name, Choi's work has the potential to impact various medical conditions related to fibrosis.

Latest Patents

One of his latest patents is a composition for preventing or treating fibrosis, which includes an inhibitor of cyclin-dependent kinase 17 (CDK17) expression or activity. This innovative composition has shown promising results in significantly reducing collagen production and cell activity in activated hepatic stellate cells, renal tubular epithelial cells, and alveolar epithelial cells. The findings indicate that this composition could be highly effective in preventing or treating fibrosis.

Career Highlights

Throughout his career, Min Seok Choi has worked with notable companies such as SK Hynix Inc. and CJ CheilJedang Corporation. His experience in these organizations has contributed to his expertise in developing innovative solutions for medical challenges.

Collaborations

Choi has collaborated with several professionals in his field, including Shinill Kang and Ji Seok Lim. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Min Seok Choi is a distinguished inventor whose work in fibrosis treatment showcases his dedication to advancing medical science. His innovative compositions and collaborations highlight his significant contributions to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…